Peter D. Adams, PhD - Sanford Burnham Prebys

Dr. Adams most recently led the Epigenetics Unit at the Beatson Institute for Cancer Research and the University of Glasgow, Institute of Cancer Sciences, in Scotland. He has also held positions at Wistar Institute (University of Pennsylvania), Drexel University and Fox Chase Cancer Center in Philadelphia.

Peter D. Adams obtained his BA in biochemistry at the University of Oxford, England and his PhD at Imperial Cancer Research Fund (now CR-UK). He did postdoctoral work with Dr. William G. Kaelin, Jr. at Dana-Farber Cancer Institute. Peter D. Adams is co-Editor-in-Chief of the journal Aging Cell.

Education

  • 1993: PhD, Signal Transduction, Imperial Cancer Research Fund (CRUK), London, UK (Dr. Peter Parker, advisor)
  • 1989: B.A., Biochemistry, Oxford University, England

Honors and Recognition

  • 2003-2008: Leukemia and Lymphoma Society Scholar
  • 1999-2001: W.W. Smith Charitable Trust Fellowship
  • 1999-2001: V Foundation Scholar
  • 1995-1996: Cancer Research Foundation of America Fellowship
  • 1993-1995: SERC/NATO Fellowship
  • 1989: B.A. with Honors in Biochemistry, Oxford University, UK
  • 1986: Awarded a Distinction in Oxford University Preliminary Examinations
  • 1984-1989: 1984-1989: Exhibition holder for Academic Achievement at Oxford University, UK
  • 1983: Lane Scholarship for Academic Achievement at King Henry VIII School, UK

Select Publications

Showing 1 of 1

Cytoplasmic chromatin triggers inflammation in senescence and cancer.

Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P, Wangensteen KJ, Simithy J, Lan Y, Lin Y, Zhou Z, Capell BC, Xu C, Xu M, Kieckhaefer JE, Jiang T, Shoshkes-Carmel M, Tanim KMAA, Barber GN, Seykora JT, Millar SE, Kaestner KH, Garcia BA, Adams PD, Berger SL

Nature 2017 Oct 19 ;550(7676):402-406